{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:31:01Z","timestamp":1777631461657,"version":"3.51.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04890-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:32:04Z","timestamp":1777433524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-dose methotrexate toxicokinetic variability persists despite standardized 24-hour infusion in childhood ALL"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8153-9643","authenticated-orcid":false,"given":"Ioannis","family":"Kyriakidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1744-9069","authenticated-orcid":false,"given":"Georgios","family":"Monastiriotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-7712","authenticated-orcid":false,"given":"Nikolaos","family":"Katzilakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-3770","authenticated-orcid":false,"given":"Iordanis","family":"Pelagiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-5110","authenticated-orcid":false,"given":"Eftichia","family":"Stiakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"4890_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00280-026-04869-x","volume":"96","author":"SJ Raha","year":"2026","unstructured":"Raha SJ, Bhatia P, Bansal D, Trehan A (2026) Effect of High-Dose Methotrexate Infusion Duration on 48-Hour Drug Levels and Toxicity in Children with Acute Lymphoblastic Leukaemia: A Quality-of-Care Study. Cancer Chemother Pharmacol 96:24. https:\/\/doi.org\/10.1007\/s00280-026-04869-x","journal-title":"Cancer Chemother Pharmacol"},{"key":"4890_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/cancers18010124","volume":"18","author":"B Pourroy","year":"2025","unstructured":"Pourroy B, Aumente MD, Koenecke C, Stanulla M, Ferreri AJM, Murciano-Carillo T, Dandapani M, Ritzmann TA, Barba P, Chatelut E et al (2025) High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers (Basel) 18:124. https:\/\/doi.org\/10.3390\/cancers18010124","journal-title":"Cancers (Basel)"},{"key":"4890_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/08880018.2023.2168809","volume":"40","author":"B \u0160kori\u0107","year":"2023","unstructured":"\u0160kori\u0107 B, Kuzmanovi\u0107 M, Jovanovi\u0107 M, Miljkovi\u0107 B, Mici\u0107 D, Jovi\u0107 M, Jovanovi\u0107 A, Vu\u010di\u0107evi\u0107 K (2023) Methotrexate Concentrations and Associated Variability Factors in High Dose Therapy of Children with Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma. Pediatr Hematol Oncol 40:446\u2013457. https:\/\/doi.org\/10.1080\/08880018.2023.2168809","journal-title":"Pediatr Hematol Oncol"},{"key":"4890_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/cpt.1957","volume":"108","author":"ZL Taylor","year":"2020","unstructured":"Taylor ZL, Mizuno T, Punt NC, Baskaran B, Navarro Sainz A, Shuman W, Felicelli N, Vinks AA, Heldrup J, Ramsey LB (2020) MTXPK.Org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post\u2010Infusion Care and Use of Glucarpidase. Clin Pharmacol Ther 108:635\u2013643. https:\/\/doi.org\/10.1002\/cpt.1957","journal-title":"Clin Pharmacol Ther"},{"key":"4890_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00280-024-04694-0","volume":"94","author":"SU Rahmayanti","year":"2024","unstructured":"Rahmayanti SU, Amalia R, Rusdiana T, Systematic Review (2024) Genetic Polymorphisms in the Pharmacokinetics of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia Patients. Cancer Chemother Pharmacol 94:141\u2013155. https:\/\/doi.org\/10.1007\/s00280-024-04694-0","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04890-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:32:10Z","timestamp":1777433530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04890-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04890-0","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Board of the University General Hospital of Heraklion; 771\/06-08-2025). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants were informed about the purpose of the study, assured of confidentiality, and their legal guardians provided written consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Observational study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"41"}}